Incidence, prevalence, and characterisation of medicines with suggested drug shortages in Europe

Study identification

• EU PAS number:
  EUPAS106954
• Study ID:
  107398
• Official title and acronym:
  Incidence, prevalence, and characterisation of medicines with suggested drug shortages in Europe
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  Bulgaria

  Denmark

  Estonia

  Finland

  France

  Germany

  Italy

  Montenegro

  Netherlands

  Portugal

  Serbia

  Spain

  Türkiye

  United Kingdom
• Study description:
  This study aims to characterise the incidence and prevalence of medicines with (suggested) shortages and their alternatives for the period 2010-2023, stratified by healthcare setting and time period in each database. Furthermore, we aim to describe incident and prevalent patients receiving a prescription / dispensation of a medicine with (suggested) shortages for the period 2010-2023, stratified by year in each database, including information on potential indication, treatment duration, and dosage.
• Study status:
  Planned

Research institutions and networks

Institutions

Pharmaco- and Device epidemiology, University of Oxford

United Kingdom

Networks

European Health Data Evidence Network (EHDEN)

Netherlands

Study timelines

Date when funding contract was signed

Planned:01/11/2018

Study start date

Planned:01/01/2010

Date of final study report

Planned:30/09/2024

Sources of funding

Other

More details on funding

EHDEN

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable